a public good project by the
Synthesis
Company
of California

© 2026

Jordi Espadaler | doi.page

0 works0 citations0 h-index

Jordi Espadaler

Kaneka (United States)(US)Universitat Internacional de Catalunya(ES)AB-Biotics (Spain)(ES)

Publications by Year

Research Areas

Probiotics and Fermented Foods, Gut microbiota and health, PI3K/AKT/mTOR signaling in cancer, Protein Structure and Dynamics, Machine Learning in Bioinformatics

Most-Cited Works

→ Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial(2017)206 cited
→ Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial(2022)200 cited
→ Viral Infections, the Microbiome, and Probiotics(2021)174 cited
→ Prediction of protein-protein interactions using distant conservation of sequence patterns and structure relationships(2005)113 cited
→ Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial(2007)109 cited
→ The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis(2019)105 cited

→ Comparing technology and regulatory landscape of probiotics as food, dietary supplements and live biotherapeutics(2023)

77 cited

→ The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase(2015)73 cited

→ ArchDB: automated protein loop classification as a tool for structural genomics(2003)66 cited

A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects. A dose-response, double-blind, placebo-controlled, randomized pilot trial.(2011)